IL88419A - Pharmaceutical formulations containing melphalan - Google Patents

Pharmaceutical formulations containing melphalan

Info

Publication number
IL88419A
IL88419A IL88419A IL8841988A IL88419A IL 88419 A IL88419 A IL 88419A IL 88419 A IL88419 A IL 88419A IL 8841988 A IL8841988 A IL 8841988A IL 88419 A IL88419 A IL 88419A
Authority
IL
Israel
Prior art keywords
melphalan
pharmaceutical formulations
formulations containing
hydrochloride
containing melphalan
Prior art date
Application number
IL88419A
Other languages
English (en)
Other versions
IL88419A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL88419A0 publication Critical patent/IL88419A0/xx
Publication of IL88419A publication Critical patent/IL88419A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
IL88419A 1987-11-19 1988-11-18 Pharmaceutical formulations containing melphalan IL88419A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878727157A GB8727157D0 (en) 1987-11-19 1987-11-19 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
IL88419A0 IL88419A0 (en) 1989-06-30
IL88419A true IL88419A (en) 1993-03-15

Family

ID=10627252

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88419A IL88419A (en) 1987-11-19 1988-11-18 Pharmaceutical formulations containing melphalan

Country Status (22)

Country Link
US (1) US4997651A (sv)
EP (1) EP0317281B1 (sv)
JP (1) JP2693191B2 (sv)
KR (1) KR970002607B1 (sv)
AT (1) ATE83922T1 (sv)
AU (1) AU619781B2 (sv)
CA (1) CA1341114C (sv)
DE (1) DE3877151T2 (sv)
DK (1) DK172794B1 (sv)
ES (1) ES2052745T3 (sv)
FI (2) FI90204C (sv)
GB (1) GB8727157D0 (sv)
GR (1) GR3007287T3 (sv)
HK (1) HK108994A (sv)
HU (3) HU206671B (sv)
IE (1) IE63996B1 (sv)
IL (1) IL88419A (sv)
LV (1) LV10179B (sv)
NZ (2) NZ239867A (sv)
PT (1) PT89028B (sv)
SG (1) SG73894G (sv)
ZA (1) ZA888674B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695751A (en) * 1993-04-08 1997-12-09 Cornell Research Foundation, Inc. Enhancing delivery of large neutral amino acid drugs
US5407672A (en) * 1993-04-08 1995-04-18 Cornell Research Foundation, Inc. Enhancing the anti-tumor effect of melphalan with L-amino acid oxidase
US6020004A (en) * 1997-04-17 2000-02-01 Amgen Inc. Biodegradable microparticles for the sustained delivery of therapeutic drugs
US5980904A (en) * 1998-11-18 1999-11-09 Amway Corporation Skin whitening composition containing bearberry extract and a reducing agent
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
WO2004000229A2 (en) * 2002-06-24 2003-12-31 Research Development Foundation Treatment of human multiple myeloma by curcumin
WO2006046934A2 (en) 2003-08-26 2006-05-04 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
US8501818B2 (en) 2005-03-14 2013-08-06 Ceptaris Therapeutics, Inc. Stabilized compositions of alkylating agents and methods of using same
US7872050B2 (en) 2005-03-14 2011-01-18 Yaupon Therapeutics Inc. Stabilized compositions of volatile alkylating agents and methods of using thereof
ES2848841T3 (es) 2008-03-27 2021-08-12 Helsinn Healthcare Sa Composiciones estabilizadas de agentes de alquilación y métodos de utilización de estas composiciones
AR066943A1 (es) * 2008-06-10 2009-09-23 Eriochem Sa Una composicion farmaceutica de melfalano
US20100311838A1 (en) 2009-05-29 2010-12-09 Pipkin James D Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
AR077384A1 (es) 2010-07-05 2011-08-24 Eriochem Sa Una formulacion farmaceutica inyectable de melfalano.
US8921596B2 (en) * 2010-11-04 2014-12-30 Emcure Pharmaceuticals, Ltd. Process for the preparation of melphalan hydrochloride
EP2701720B1 (en) 2011-04-28 2017-07-12 Oncopeptides AB Lyophilized preparation of cytotoxic dipeptides
WO2014065751A1 (en) 2012-10-26 2014-05-01 Oncopeptides Ab Lyophilized preparations of melphalan flufenamide
WO2014141294A2 (en) 2013-03-11 2014-09-18 Biophore India Pharmaceuticals Pvt. Ltd. An improved process for the synthesis of melphalan and the hydrochloride salt
ITMI20130896A1 (it) * 2013-05-31 2014-12-01 Farmabios Spa Processo di purificazione di melphalan
HUE042681T2 (hu) * 2015-03-06 2019-07-29 Leadiant Biosciences Sa In Liquidazione Myeloma multiplex roneparstat kombinációs terápiája
US10537520B2 (en) * 2015-06-30 2020-01-21 Leiutis Pharmaceuticals Pvt. Ltd. Stable liquid formulations of melphalan
KR20200136997A (ko) * 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형
US10682326B1 (en) 2019-06-03 2020-06-16 Shilpa Medicare Limited Stable melphalan liquid injectable formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB750155A (en) * 1953-03-17 1956-06-13 Nat Res Dev Substituted alanines
US3032585A (en) * 1954-12-03 1962-05-01 Nat Res Dev Process for the production of p-bis-(2-chloroethyl)-aminophenylalanine
DE1292660B (de) * 1963-04-24 1969-04-17 Ural Polytechnitscheskij I Im Verfahren zur Herstellung von p-(Bis-ª‰-chloraethyl-amino)-phenylalanin-hydrochlorid
US4029778A (en) * 1969-01-23 1977-06-14 Aktiebolaget Leo Cortical steroid nitrogen mustard compositions and treatment therewith
RO57195A2 (sv) * 1970-11-30 1974-09-01
FR2285855A1 (fr) * 1974-09-25 1976-04-23 Kohjin Co Composition therapeutique lyophilisee a base de sel de cyclocytidine et son procede de preparation
JPS59186924A (ja) * 1983-04-08 1984-10-23 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤
US4696814A (en) * 1985-08-21 1987-09-29 Warner-Lambert Company Parenteral phenytoin compositions
JPS62192357A (ja) * 1986-02-19 1987-08-22 Kureha Chem Ind Co Ltd Ｎ−フタロイル−ｐ−ニトロ−Ｌ−フエニルアラニンの製造方法

Also Published As

Publication number Publication date
AU619781B2 (en) 1992-02-06
AU2574888A (en) 1989-05-25
KR890007729A (ko) 1989-07-05
HK108994A (en) 1994-10-14
HU9100335D0 (en) 1991-08-28
IL88419A0 (en) 1989-06-30
JPH01153628A (ja) 1989-06-15
JP2693191B2 (ja) 1997-12-24
LV10179B (en) 1995-06-20
NZ239867A (en) 1992-11-25
EP0317281A3 (en) 1989-08-09
FI924668A0 (fi) 1992-10-15
DK646688A (da) 1989-05-20
KR970002607B1 (ko) 1997-03-06
IE63996B1 (en) 1995-06-28
GR3007287T3 (sv) 1993-07-30
HU910336D0 (en) 1991-08-28
HU207286B (en) 1993-03-29
FI885358A0 (sv) 1988-11-18
HUT48198A (en) 1989-05-29
SG73894G (en) 1994-11-25
HU206671B (en) 1992-12-28
ZA888674B (en) 1990-07-25
FI102275B1 (sv) 1998-11-13
FI90204C (sv) 1994-01-10
IE883447L (en) 1989-05-19
FI90204B (sv) 1993-09-30
CA1341114C (en) 2000-10-10
FI924668A (fi) 1992-10-15
EP0317281B1 (en) 1992-12-30
LV10179A (lv) 1994-10-20
PT89028A (pt) 1988-12-01
ES2052745T3 (es) 1994-07-16
HU203197B (en) 1991-06-28
GB8727157D0 (en) 1987-12-23
DE3877151T2 (de) 1993-07-15
FI102275B (sv) 1998-11-13
US4997651A (en) 1991-03-05
FI885358A (sv) 1989-05-20
DK646688D0 (da) 1988-11-18
EP0317281A2 (en) 1989-05-24
PT89028B (pt) 1993-02-26
DK172794B1 (da) 1999-07-19
DE3877151D1 (de) 1993-02-11
NZ227004A (en) 1992-11-25
ATE83922T1 (de) 1993-01-15

Similar Documents

Publication Publication Date Title
IL88419A (en) Pharmaceutical formulations containing melphalan
IL86782A (en) Amino acid derivatives, processes for the preparation thereof and pharmaceutical compositions comprising the same
ES2032898T3 (es) Procedimiento para la fabricacion de una locion topica.
GB2133983B (en) Method for preparing galenic formulations particularly for pharmaceutical, dietary, cosmetic and diagnostic uses
IL68456A0 (en) Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles
PT80752A (en) Process for preparing solid medicament formulations containing dihydropyridines
IL61989A (en) 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
GR75738B (sv)
IL86173A0 (en) Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
MY105860A (en) Pharmaceutical formulations.
ES8607016A1 (es) Preparado solido de nifedipina
DE3065087D1 (en) Piperidine derivatives of 3-hydroxy-thiophene-2-carboxylic acid esters, their preparation, and pharmaceutical preparations containing them
GB8700942D0 (en) Pharmaceutical veterinary & cosmetic compositions

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired